Onyebuchi Ezigbo in Abuja
The federal government has said investments in the health sector have contributed significantly to immunisation, with 16.6 million children reached, while malaria prevalence in Nigeria has dropped from 27 percent to 15.2 percent, representing a 12 percent reduction.
The Executive Director of NPHCDA, Dr. Muyi Aina, disclosed this at the IMPACT End-of-Project Dissemination and Transitions Forum in Abuja.
The Immunization-Plus and Malaria Progress by Accelerating Coverage and Transforming Services (IMPACT) Project was jointly implemented by the NMEP and the National Primary Health Care Development Agency (NPHCDA), with funding support from the World Bank.
Muyi Aina said the project represented a very important investment by the Government of Nigeria to strengthen primary healthcare delivery, improve immunisation coverage and expand access to essential malaria interventions.
He said the investments contributed significantly to immunisation, with 16.6 million children reached, while the proportion of women who received three doses of intermittent preventive treatment (IPTp3) increased from 31 percent to 33 percent.
He also noted a four percent increase in the proportion of children who use insecticide-treated mosquito nets.
Aina urged states, local governments and communities to own the infrastructure, equipment and other assets provided through the project, and ensure continuity to sustain the gains.
While unveiling the report, the National Coordinator, National Malaria Elimination Programme (NMEP), Dr. Nnenna Ogbuluafor said the project, whose main goal was to reduce mortality of under-five children and pregnant women and improve utilisation of immunisation-plus and malaria services at public health facilities, had largely achieved its targets.
“At the start of the Project, the malaria prevalence for Nigeria stood at 27%, however, at this point of close-out, it is now at 15.2% (according to 2025 MIS), a 12% reduction,” she said.
She noted the figure did not emphasise the number of deaths averted and persons protected from the malaria scourge.
Through the support of IMPACT, she said, the country was able to implement the 2025 Nigeria Malaria Indicator Survey with very minimal support from other partners, for the very first time.
Other notable achievements include the development of the National Malaria Strategic Plan 2026-2030, support to the implementation of Larval Source Management in the six World Bank-supported states – the largest scale ever in the country – and support of stocks of locally produced new generation insecticide-treated nets to the states.
She also listed the phased deployment of the Affordable Diagnostics and Medicines Facility for Malaria (ADMFm), focusing on NAFDAC-approved local manufacturers, channelled through Patent and Proprietary Medicine Vendors (PPMVs) in rural and underserved areas.
Ogbuluafor said IMPACT had also strengthened the health system through stronger digital platforms for data management, support to pharmaceutical companies to improve quality antimalarial commodities through NIPRD, a stronger healthcare value chain through PVAC, availability of entomological data through NIMR, and improved pharmacovigilance through NAFDAC.
She expressed confidence that with the process laid and catalysed, every effort would be put into sustaining the gains, particularly in the malaria focus states.

